Excessively High-Affinity Single-Chain Fragment Variable Region in a Chimeric Antigen Receptor Can Counteract T-Cell Proliferation

被引：0
|
作者：
Watanabe, Keisuke [1 ]
Terakura, Seitaro [1 ]
Uchiyama, Susumu [2 ]
Martens, Anton C. [3 ]
van Meerten, Tom [4 ]
Kiyoi, Hitoshi [1 ]
Nishida, Tetsuya [1 ]
Naoe, Tomoki [5 ]
Murata, Makoto [1 ]
机构：
[1] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan
[2] Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan
[3] Univ Med Ctr Utrecht, Utrecht, Netherlands
[4] Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands
[5] Natl Hosp Org, Nagoya Med Ctr, Nagoya, Aichi, Japan
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Engineered exosome-mediated messenger RNA and single-chain variable fragment delivery for human chimeric antigen receptor T-cell engineering
    Si, Ke
    Dai, Zhu
    Li, Zhanping
    Ye, Zheng
    Ding, Bo
    Feng, Songwei
    Sun, Bo
    Shen, Yang
    Xiao, Zhongdang
    CYTOTHERAPY, 2023, 25 (06) : 615 - 624
  • [2] A SOLUBLE, SINGLE-CHAIN T-CELL RECEPTOR FRAGMENT ENDOWED WITH ANTIGEN-COMBINING PROPERTIES
    NOVOTNY, J
    GANJU, RK
    SMILEY, ST
    HUSSEY, RE
    LUTHER, MA
    RECNY, MA
    SILICIANO, RF
    REINHERZ, EL
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) : 8646 - 8650
  • [3] Computationally Guided Design of Single-Chain Variable Fragment Improves Specificity of Chimeric Antigen Receptors
    Krokhotin, Andrey
    Du, Hongwei
    Hirabayashi, Koichi
    Popov, Konstantin
    Kurokawa, Tomohiro
    Wan, Xinhui
    Ferrone, Soldano
    Dotti, Gianpietro
    Dokholyan, Nikolay, V
    MOLECULAR THERAPY-ONCOLYTICS, 2019, 15 : 30 - 37
  • [4] Expression and Functional Properties of an Anti-Triazophos High-Affinity Single-Chain Variable Fragment Antibody with Specific Lambda Light Chain
    Liu, Rui
    Liang, Xiao
    Xiang, Dandan
    Guo, Yirong
    Liu, Yihua
    Zhu, Guonian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (06):
  • [5] Phage antibody library screening for the selection of novel high-affinity human single-chain variable fragment against gastrin receptor: an in silico and in vitro study
    Sepideh Jalilzadeh-Razin
    Malihe Mantegi
    Mohammad R. Tohidkia
    Yaghub Pazhang
    Mohammad M. Pourseif
    Jaleh Barar
    Yadollah Omidi
    DARU Journal of Pharmaceutical Sciences, 2019, 27 : 21 - 34
  • [6] Phage antibody library screening for the selection of novel high-affinity human single-chain variable fragment against gastrin receptor: an in silico and in vitro study
    Jalilzadeh-Razin, Sepideh
    Mantegi, Malihe
    Tohidkia, Mohammad R.
    Pazhang, Yaghub
    Pourseif, Mohammad M.
    Barar, Jaleh
    Omidi, Yadollah
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 27 (01) : 21 - 34
  • [7] A SOLUBLE, SINGLE CHAIN T-CELL RECEPTOR FRAGMENT ENDOWED WITH ANTIGEN-COMBINING PROPERTIES
    NOVOTNY, J
    GANJU, RK
    SMILEY, ST
    HUSSEY, RE
    LUTHER, MA
    RECNY, MA
    SILICIANO, RF
    REINHERZ, EL
    FASEB JOURNAL, 1992, 6 (01): : A351 - A351
  • [8] CHARACTERIZATION OF A SINGLE-CHAIN ANTIBODY TO THE BETA-CHAIN OF THE T-CELL RECEPTOR
    CHO, BK
    SCHODIN, BA
    KRANZ, DM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (43) : 25819 - 25826
  • [9] Single-chain variable fragment affinity tuning can optimize anti-AML CAR-NK cell functionality
    Rahnama, Ruyan
    Kizerwetter, Monika
    Yang, Huilin
    Christodoulou, Ilias
    Guaraca, Christian
    Holl, Natalie Jordan
    Choe, Jun
    Vorri, Stamatia C.
    Zinsky, Megan
    Jones, Danielle G.
    Espinoza, Nikol Garcia
    Kuo, Yun-Huai
    Zahurak, Marianna
    Varadhan, Ravi
    Spangler, Jamie B.
    Bonifant, Challice L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (02)
  • [10] Single-Chain Variable Fragment Affinity Tuning Can Optimize Anti-AML CAR-NK Cell Functionality
    Rahnama, Ruyan
    Yang, Huilin
    Kizerwetter, Monika
    Holl, Natalie
    Choe, Jun
    Vorri, Stamatia
    Modi, Arjun
    Spangler, Jamie
    Bonifant, Challice
    MOLECULAR THERAPY, 2024, 32 (04) : 202 - 203
12345